Search Results - "Bresse, Xavier"

Refine Results
  1. 1

    Epidemiological and economic burden of potentially HPV-related cancers in France by Abramowitz, Laurent, Lacau Saint Guily, Jean, Moyal-Barracco, Micheline, Bergeron, Christine, Borne, Hélène, Dahlab, André, Bresse, Xavier, Uhart, Mathieu, Cancalon, Charlotte, Catella, Laura, Bénard, Stève

    Published in PloS one (20-09-2018)
    “…Human papillomaviruses (HPV) infection is now known to be responsible for almost all cervical cancers, and for a substantial fraction of Head and Neck cancers…”
    Get full text
    Journal Article
  2. 2

    Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France by de Rycke, Yann, Tubach, Florence, Lafourcade, Alexandre, Guillo, Sylvie, Dalichampt, Marie, Dahlab, André, Bresse, Xavier, Uhart, Mathieu, Bergeron, Christine, Borne, Hélène, Cancalon, Charlotte, Lajoinie, Audrey, Bénard, Stève

    Published in PloS one (13-02-2020)
    “…Until 2018, cervical cancer screening in France was an unorganized individual screening, with the exception of some pilot programs in some territories. We…”
    Get full text
    Journal Article
  3. 3

    Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe by Marty, Rémi, Roze, Stéphane, Bresse, Xavier, Largeron, Nathalie, Smith-Palmer, Jayne

    Published in BMC cancer (08-01-2013)
    “…HPV is related to a number of cancer types, causing a considerable burden in both genders in Europe. Female vaccination programs can substantially reduce the…”
    Get full text
    Journal Article
  4. 4

    Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland by Szucs, Thomas D, Kressig, Reto W, Papageorgiou, Manto, Kempf, Werner, Michel, Jean-Pierre, Fendl, Anton, Bresse, Xavier

    Published in Human vaccines (01-07-2011)
    “…A life-attenuated vaccine aimed at preventing herpes zoster (HZ) and its main complication, post-herpetic neuralgia (PHN), will soon be available in Europe…”
    Get full text
    Journal Article
  5. 5

    Loss of chance associated with sub-optimal HPV vaccination coverage rate in France by Uhart, Mathieu, Adam, Marjorie, Dahlab, André, Bresse, Xavier

    Published in Papillomavirus research (01-06-2017)
    “…Since 2007, HPV vaccination programs have been implemented in Europe. Significant real-life impact has already been reported in countries where the programs…”
    Get full text
    Journal Article
  6. 6

    Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France by Majed, Laureen, Bresse, Xavier, El Mouaddin, Nadia, Schmidt, Aurélie, Daniels, Vincent J., Pavelyev, Andrew, Levy-Bachelot, Laurie, Elbasha, Elamin

    Published in Vaccine (08-01-2021)
    “…•In France, gender-neutral vaccination could have a significant public health impact.•GNV could avoid 17,000 cancers and over 1 million of genital warts…”
    Get full text
    Journal Article
  7. 7

    Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost-effectiveness analysis by Bresse, Xavier, Goergen, Christoph, Prager, Bernhard, Joura, Elmar

    “…The International Agency for Research on Cancer acknowledges that HPV is a human carcinogen affecting both sexes. This study aimed to evaluate the public…”
    Get more information
    Journal Article
  8. 8

    Mind the gaps: What's missing from current economic evaluations of universal HPV vaccination? by Marsh, Kevin, Chapman, Ruth, Baggaley, Rebecca F, Largeron, Nathalie, Bresse, Xavier

    Published in Vaccine (24-06-2014)
    “…Highlights • Economic studies do not capture all the value of universal HPV vaccination. • Most studies capture the value of health gains but a fraction of…”
    Get full text
    Journal Article
  9. 9

    Role of vaccination in the sustainability of healthcare systems by Largeron, Nathalie, Lévy, Pierre, Wasem, Jürgen, Bresse, Xavier

    “…The use of vaccines to prevent diseases in children, adults, and the elderly results in fewer medical visits, diagnostic tests, treatments, and…”
    Get full text
    Journal Article
  10. 10

    Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis by Bresse, Xavier, Annemans, Lieven, Préaud, Emmanuelle, Bloch, Karine, Duru, Gérard, Gauthier, Aline

    “…This study assesses the cost-effectiveness of vaccination against herpes zoster (HZ) and postherpetic neuralgia in France, using a published Markov model. The…”
    Get more information
    Journal Article
  11. 11

    A comparative public health and budget impact analysis of pneumococcal vaccines: The French case by Jiang, Yiling, Gervais, Frédéric, Gauthier, Aline, Baptiste, Charles, Martinon, Prescilla, Bresse, Xavier

    Published in Human vaccines & immunotherapeutics (02-09-2015)
    “…In 2002, a pneumococcal conjugate vaccine (PCV) was introduced to French infants and toddlers. A change has been witnessed in the incidence of pneumococcal…”
    Get full text
    Journal Article
  12. 12

    A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus by Jiang, Yiling, Gauthier, Aline, Postma, Maarten J, Ribassin-Majed, Laureen, Largeron, Nathalie, Bresse, Xavier

    Published in Human vaccines & immunotherapeutics (01-11-2013)
    “…A critical review of cost-effectiveness analyses of HPV vaccination in males was conducted and nine studies were identified in different countries. Due to the…”
    Get full text
    Journal Article
  13. 13

    Cost-effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Germany by Jiang, Yiling, Gauthier, Aline, Annemans, Lieven, van der Linden, Mark, Nicolas-Spony, Laurence, Bresse, Xavier

    “…The introduction of routine infant vaccination against pneumococcal disease has resulted in a decreased overall invasive pneumococcal disease incidence in…”
    Get more information
    Journal Article
  14. 14

    A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France by Bresse, Xavier, Adam, Marjorie, Largeron, Nathalie, Roze, Stephane, Marty, Rémi

    Published in Human vaccines & immunotherapeutics (01-04-2013)
    “…The aim was to compare the epidemiological and economic impact of 16/18 bivalent and 6/11/16/18 quadrivalent HPV vaccination in France, considering differences…”
    Get full text
    Journal Article
  15. 15

    A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany by Jiang, Yiling, Gauthier, Aline, Annemans, Lieven, van der Linden, Mark, Nicolas-Spony, Laurence, Bresse, Xavier

    “…To assess the comparative public health and budget impact over 5 years of several pneumococcal vaccination strategies (23-valent pneumococcal polysaccharide…”
    Get more information
    Journal Article
  16. 16

    How to improve vaccine acceptability (evaluation, pharmacovigilance, communication, public health, mandatory vaccination, fears and beliefs) by Dutilleul, Alain, Morel, Jacques, Schilte, Clémentine, Launay, Odile

    Published in Therapie (01-02-2019)
    “…A flagship recommendation of the citizen's steering committee on immunization, the mandatory immunization for infants extended to 11 vaccines, introduced in…”
    Get more information
    Journal Article
  17. 17

    What is the budget impact of a new treatment or new health technology arriving on the market? by Dervaux, Benoit, Le Fur, Camille, Dubois, Sophie, Josseran, Anne

    Published in Therapie (01-02-2017)
    “…In France, market access for innovative drugs (level I, II & III improvement of medical service rendered having significant impact on health insurance…”
    Get more information
    Journal Article
  18. 18

    Activity and cost related to hospital management of herpes zoster in France: focus on ophthalmic herpes zoster by Berrut, Gilles, Vainchtock, Alexandre, Fernandez, José, Bresse, Xavier, Baptiste, Charles, De Decker, Laure

    “…Herpes zoster secondary to reactivation and replication of the varicella zoster virus (VZV) caused a painful disease which impact the quality of life. Among…”
    Get full text
    Journal Article
  19. 19

    Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis by Fardellone, Patrice, Cortet, Bernard, Legrand, Erick, Bresse, Xavier, Bisot-Locard, Ségolène, Vigneron, Anne-Marie, Beresniak, Ariel

    Published in Joint, bone, spine : revue du rhumatisme (01-01-2010)
    “…Abstract Objectives To compare effectiveness, associated cost of outcomes and cost-effectiveness of a single annual infusion of zoledronic acid versus current…”
    Get full text
    Journal Article
  20. 20